DNA flow cytometry of follicular non-Hodgkin's lymphoma
- PMID: 2013622
- PMCID: PMC496940
- DOI: 10.1136/jcp.44.3.215
DNA flow cytometry of follicular non-Hodgkin's lymphoma
Abstract
S-phase fraction, an index of cellular proliferation, and DNA ploidy were measured by DNA flow cytometry in a retrospective study of lymph node biopsy specimens from 83 cases (before treatment) of follicular non-Hodgkin's lymphoma, Working Formulation categories B and C. The correlations between these measures and survival, clinical stage, symptoms and histopathological factors were investigated. Aneuploidy was rare (n = 16) and had no effect on length of survival or transformation to high grade lymphoma. The overall mean S-phase fraction was 3.6%; for the whole series increasing S-phase fraction was associated with decreased survival. A high S-phase fraction (more than 5%) in initial biopsy specimens was also associated with an increased risk of subsequent high grade transformation at relapse. There was no difference between the survival or proliferative activity of tumours composed of mainly small cleaved cells compared with those composed of mixed small and large cells. There was no difference in survival or proliferative activity between tumours showing a pure follicular growth pattern and those with a mixed follicular and diffuse growth pattern. Multifactorial analysis showed that an S-phase fraction of more than 5% and B symptoms were the most important factors determining survival in these follicular non-Hodgkin's lymphomas.
Similar articles
-
Flow cytometric analysis of DNA ploidy in large cleaved cell lymphomas.Hematol Oncol. 1990 Nov-Dec;8(6):339-46. doi: 10.1002/hon.2900080606. Hematol Oncol. 1990. PMID: 2286357
-
Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.Diagn Cytopathol. 2003 Oct;29(4):194-9. doi: 10.1002/dc.10298. Diagn Cytopathol. 2003. PMID: 14506670
-
Prognostic relevance of ploidy and proliferative activity evaluation by flow cytometry in poor prognosis non-Hodgkin's lymphomas.Haematologica. 1992 Jan-Feb;77(1):84-6. Haematologica. 1992. PMID: 1398287
-
Prognostic importance of DNA flow cytometry in non-Hodgkin's lymphomas.J Clin Pathol. 1986 May;39(5):542-6. doi: 10.1136/jcp.39.5.542. J Clin Pathol. 1986. PMID: 3722408 Free PMC article.
-
Clinical relevance of markers of cell proliferation in human lymphoid malignancies: a concise review.Eur J Cancer Clin Oncol. 1982 Dec;18(12):1229-35. doi: 10.1016/0277-5379(82)90123-7. Eur J Cancer Clin Oncol. 1982. PMID: 6762302 Review.
Cited by
-
Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas.Am J Pathol. 1993 Mar;142(3):755-63. Am J Pathol. 1993. PMID: 7681257 Free PMC article.
-
Clinical and molecular prognostic factors in follicular lymphoma.Curr Oncol Rep. 2006 Sep;8(5):359-67. doi: 10.1007/s11912-006-0059-8. Curr Oncol Rep. 2006. PMID: 16901397 Review.
-
Tumour cell proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkin's lymphomas.Br J Cancer. 1998 Jun;77(11):1839-41. doi: 10.1038/bjc.1998.305. Br J Cancer. 1998. PMID: 9667655 Free PMC article.
-
Proliferation and apoptosis in malignant and normal cells in B-cell non-Hodgkin's lymphomas.Br J Cancer. 1998 Jun;77(11):1832-8. doi: 10.1038/bjc.1998.304. Br J Cancer. 1998. PMID: 9667654 Free PMC article.
-
Nucleolar organiser regions and survival in patients with non-Hodgkin's lymphomas classified by the working formulation.J Clin Pathol. 1993 Oct;46(10):943-7. doi: 10.1136/jcp.46.10.943. J Clin Pathol. 1993. PMID: 8227414 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources